204 related articles for article (PubMed ID: 35806336)
1. Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet.
Reyes C; Nova-Lamperti E; Duran-Sandoval D; Rojas D; Gajardo J; Guzman-Gutierrez E; Bustos-Ruiz C; Ormazábal V; Zúñiga FA; Escudero C; Aguayo C
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806336
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein.
Veas C; Jara C; Willis ND; Pérez-Contreras K; Gutierrez N; Toledo J; Fernandez P; Radojkovic C; Zuñiga FA; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2016 Apr; 67(4):326-35. PubMed ID: 26771151
[TBL] [Abstract][Full Text] [Related]
3. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.
Biocca S; Filesi I; Mango R; Maggiore L; Baldini F; Vecchione L; Viola A; Citro G; Federici G; Romeo F; Novelli G
J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942
[TBL] [Abstract][Full Text] [Related]
4. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
Jiang Q; Wang D; Han Y; Han Z; Zhong W; Wang C
Int J Biochem Cell Biol; 2015 Dec; 69():142-52. PubMed ID: 26510581
[TBL] [Abstract][Full Text] [Related]
5. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
[No Abstract] [Full Text] [Related]
7. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.
Wang Z; Chen J; Zeng Z; Zhang Q; Du G; Guo X; Wei Y
Mol Med; 2022 Mar; 28(1):26. PubMed ID: 35236285
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
Ying W; Meiyan S; Wen C; Kaizu X; Meifang W; Liming L
Redox Rep; 2023 Dec; 28(1):2218684. PubMed ID: 37278349
[TBL] [Abstract][Full Text] [Related]
9. LOX-1/LOXIN: the yin/yang of atheroscleorosis.
Mango R; Predazzi IM; Romeo F; Novelli G
Cardiovasc Drugs Ther; 2011 Oct; 25(5):489-94. PubMed ID: 21904818
[TBL] [Abstract][Full Text] [Related]
10. Oxidized LDL, LOX-1 and atherosclerosis.
Mitra S; Goyal T; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
[TBL] [Abstract][Full Text] [Related]
11. Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating Lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades.
Feng Z; Yang X; Zhang L; Ansari IA; Khan MS; Han S; Feng Y
Phytother Res; 2018 Dec; 32(12):2417-2427. PubMed ID: 30136446
[TBL] [Abstract][Full Text] [Related]
12. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.
Liu Z; Han Y; Li L; Lu H; Meng G; Li X; Shirhan M; Peh MT; Xie L; Zhou S; Wang X; Chen Q; Dai W; Tan CH; Pan S; Moore PK; Ji Y
Br J Pharmacol; 2013 Aug; 169(8):1795-809. PubMed ID: 23713790
[TBL] [Abstract][Full Text] [Related]
13. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression.
Wang Z; Guo X; Zhang Q; Du G; Zeng Z; Zheng C; Wei Y
Int J Med Sci; 2021; 18(16):3652-3664. PubMed ID: 34790037
[No Abstract] [Full Text] [Related]
14. LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline.
Singh A; Srinivasan AK; Chakrapani LN; Kalaiselvi P
Oxid Med Cell Longev; 2019; 2019():8285730. PubMed ID: 31885819
[TBL] [Abstract][Full Text] [Related]
15. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.
Chen J; Liu Y; Liu H; Hermonat PL; Mehta JL
Biochem J; 2006 Jan; 393(Pt 1):255-65. PubMed ID: 16173915
[TBL] [Abstract][Full Text] [Related]
16. PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages.
Ding Z; Liu S; Wang X; Theus S; Deng X; Fan Y; Zhou S; Mehta JL
Cardiovasc Res; 2018 Jul; 114(8):1145-1153. PubMed ID: 29617722
[TBL] [Abstract][Full Text] [Related]
17. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells.
Jiang JX; Zhang SJ; Liu YN; Lin XX; Sun YH; Shen HJ; Yan XF; Xie QM
Eur J Pharmacol; 2014 Mar; 727():43-51. PubMed ID: 24486707
[TBL] [Abstract][Full Text] [Related]
18. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low density lipoprotein induces endothelial-to-mesenchymal transition by stabilizing Snail in human aortic endothelial cells.
Su Q; Sun Y; Ye Z; Yang H; Li L
Biomed Pharmacother; 2018 Oct; 106():1720-1726. PubMed ID: 30119247
[TBL] [Abstract][Full Text] [Related]
20. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
